Fri, 03 May 2013 08:45:00 GMT — Missouri Attorney General Chris Koster says more than $600,000 has been recovered for the Missouri Medicaid program as part of a national settlement against the drug-maker Amgen Inc. Amgen agreed last month to pay $24.9 million to resolve claims it gave kickbacks to increase sales of its anemia drug Aranesp. Missouri was among several states that accused Amgen of a scheme aimed at inducing nursing home professionals to dispense Aranesp over competing drugs. Missouri's share is $603,493. Aranesp is one of Amgen's biggest-selling drugs, though sales have fallen sharply since 2007 because of a series of safety problems and restrictions on its use. In December, Amgen agreed to pay $762 million to resolve federal litigation accusing it of marketing Aranesp for unapproved uses.
KRCG offers coverage of news, sports, weather and local events in the Columbia and Jefferson City, Missouri area, including the communities of New Bloomfield, Shaw, Boonville, Ashland, Hallsville, Sturgeon, Centralia, Mexico, Auxvasse, Fulton, California, Tipton, Eldon, Wardsville, Westphalia and Sedalia, Missouri.